• 
  IDIGH Research Day 2021

  Join us on May 21 for our first virtual research day! Register here
• 
  Don't miss the next seminar!

  Click here for more info. 
• 
  McGill's bicentennial time capsule

  Dr. Nitika Pai imagines the future of diagnostics in HIV/STIs!
• 
  A spring in your step!

  The first event of 2021 organized by our trainees. 
• 
  CIHR Project Grant (fall 2020)

  Congratulations to the new CIHR Project Grant recipients!
• 
  RI-MUHC 2020 Annual Report

  Kudos to IDIGH members featured inside the 2020 report!
• 
  Quality of Tuberculosis Care

  This free eBook, edited by Professors Madhukar Pai & Zelalem Temesgen is a compilation of a series on Quality of TB Care.
• 
  IDIGH Symposium

  The IDIGH Symposium 2019 was a success with 293 attendees. Photos are available. 
• 
  IDIGH Travel Awards 2019

  Congratulations to the awardees!
• 
  New trainee committee for 2019-2020

  Meet the new team!
• 
  IAS awards

  Dr. Stéphane Isnard from Dr. Routy lab was honoured for his research on gut permeability in HIV.
• 
  Antibiotic Sentinel

  Winner of the MI4 Innovation Prize of the Clinical Innovation Competition.

Infectious Diseases and Immunity in Global Health Program

The Infectious Diseases and Immunity in Global Health Program is integrating research in infectious diseases, immunity and global health at the Research Institute of the McGill University Health Centre (RI-MUHC) into work groups with a strong translational focus.

The translational topics are (i) diagnostics, (ii) therapeutics and prevention and (iii) epidemiology and health outcomes. A distinguishing feature of the program are cross-disciplinary research teams encompassing basic biomedical, clinical and health outcomes research that jointly work on novel ways to improve patient well-being and population health in focus diseases.

Program initiatives are well integrated with ongoing research efforts of other groups at McGill University, as well as national and international centres and organizations dedicated to infectious and immune-mediated diseases. This provides the organizational framework for cutting edge research at the front lines of the most pressing global disease threats by program scientists.